OBJECTIVE: Although substance use (SU) is elevated in ADHD and both are associated with disrupted emotional functioning, little is known about how emotions and SU interact in ADHD. We used a mixed qualitative-quantitative approach to explore this relationship. METHOD: Narrative comments were coded for 67 persistent (50 ADHD, 17 local normative comparison group [LNCG]) and 25 desistent (20 ADHD, 5 LNCG) substance users from the Multimodal Treatment Study of Children with ADHD (MTA) adult follow-up (21.7-26.7 years-old). RESULTS: SU persisters perceived SU positively affects emotional states and positive emotional effects outweigh negative effects. No ADHD group effects emerged. Qualitative analysis identified perceptions that cannabis enhanced positive mood for ADHD and LNCG SU persisters, and improved negative mood and ADHD for ADHD SU persisters. CONCLUSION: Perceptions about SU broadly and mood do not differentiate ADHD and non-ADHD SU persisters. However, perceptions that cannabis is therapeutic may inform ADHD-related risk for cannabis use.
OBJECTIVE: Although substance use (SU) is elevated in ADHD and both are associated with disrupted emotional functioning, little is known about how emotions and SU interact in ADHD. We used a mixed qualitative-quantitative approach to explore this relationship. METHOD: Narrative comments were coded for 67 persistent (50 ADHD, 17 local normative comparison group [LNCG]) and 25 desistent (20 ADHD, 5 LNCG) substance users from the Multimodal Treatment Study of Children with ADHD (MTA) adult follow-up (21.7-26.7 years-old). RESULTS:SU persisters perceived SU positively affects emotional states and positive emotional effects outweigh negative effects. No ADHD group effects emerged. Qualitative analysis identified perceptions that cannabis enhanced positive mood for ADHD and LNCG SU persisters, and improved negative mood and ADHD for ADHDSU persisters. CONCLUSION: Perceptions about SU broadly and mood do not differentiate ADHD and non-ADHDSU persisters. However, perceptions that cannabis is therapeutic may inform ADHD-related risk for cannabis use.
Entities:
Keywords:
ADHD; MTA study; qualitative research; substance use
Authors: E D Levin; C K Conners; E Sparrow; S C Hinton; D Erhardt; W H Meck; J E Rose; J March Journal: Psychopharmacology (Berl) Date: 1996-01 Impact factor: 4.530
Authors: Brooke S G Molina; Stephen P Hinshaw; L Eugene Arnold; James M Swanson; William E Pelham; Lily Hechtman; Betsy Hoza; Jeffery N Epstein; Timothy Wigal; Howard B Abikoff; Laurence L Greenhill; Peter S Jensen; Karen C Wells; Benedetto Vitiello; Robert D Gibbons; Andrea Howard; Patricia R Houck; Kwan Hur; Bo Lu; Sue Marcus Journal: J Am Acad Child Adolesc Psychiatry Date: 2013-02-08 Impact factor: 8.829
Authors: F Joseph McClernon; Scott H Kollins; Avery M Lutz; David P Fitzgerald; Desiree W Murray; Christina Redman; Jed E Rose Journal: Psychopharmacology (Berl) Date: 2007-11-25 Impact factor: 4.530
Authors: Brooke S G Molina; Andrea L Howard; James M Swanson; Annamarie Stehli; John T Mitchell; Traci M Kennedy; Jeffery N Epstein; L Eugene Arnold; Lily Hechtman; Benedetto Vitiello; Betsy Hoza Journal: J Child Psychol Psychiatry Date: 2018-01-08 Impact factor: 8.982
Authors: Peter S Jensen; Kumi Yuki; Desiree Murray; John T Mitchell; Thomas Weisner; Steven Hinshaw; Brooke Molina; James Swanson; L Eugene Arnold; Lily Hechtman; Karen Wells Journal: J Atten Disord Date: 2017-04-19 Impact factor: 3.256
Authors: Callie M Ginapp; Grace Macdonald-Gagnon; Gustavo A Angarita; Krysten W Bold; Marc N Potenza Journal: Front Psychiatry Date: 2022-08-11 Impact factor: 5.435
Authors: John T Mitchell; Sara LeGrand; Lisa B Hightow-Weidman; Mehri S McKellar; Angela Dm Kashuba; Mackenzie Cottrell; Tony McLaurin; Goutam Satapathy; F Joseph McClernon Journal: JMIR Mhealth Uhealth Date: 2018-09-10 Impact factor: 4.773